| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 14 |
| 1 | CLOZAPINE | 11 |
| 2 | PREDNISONE | 7 |
| 3 | BENDAMUSTINE HCL | 6 |
| 4 | CYCLOPHOSPHAMIDE | 6 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 6 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 6 |
| 7 | LENALIDOMIDE | 6 |
| 8 | OBINUTUZUMAB | 6 |
| 9 | DOXORUBICIN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFTAROLINE FOSAMIL | 2 | 0.0024 |
| 1 | RITUXIMAB AND HYALURONIDASE | 1 | 0.0022 |
| 2 | CALCIUM CHLORIDE INJECTION | 2 | 0.0006 |
| 3 | PIMECROLIMUS | 1 | 0.0006 |
| 4 | UREA | 1 | 0.0005 |
| 5 | ALBUMIN HUMAN | 2 | 0.0004 |
| 6 | BENDAMUSTINE HCL | 6 | 0.0004 |
| 7 | GLYCERIN SUPPOSITORY | 1 | 0.0004 |
| 8 | GLYCERIN SUPPOSITORIES | 1 | 0.0004 |
| 9 | ALBUMIN (HUMAN) | 2 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 2 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 3 | 0.0001 |
| 3 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 19 | 0.0001 |
| 5 | Penem Antibacterial [EPC] | 2 | 0.0001 |
| 6 | Non-Standardized Plant Allergenic Extract [EPC] | 1 | 0.0001 |
| 7 | Polyene Antifungal [EPC] | 2 | 0.0000 |
| 8 | Leukocyte Growth Factor [EPC] | 5 | 0.0000 |
| 9 | Alkylating Drug [EPC] | 7 | 0.0000 |